RGBP · Regen BioPharma Inc · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“Without additional funding, there is substantial doubt about the Company's ability to continue as a going concern for the twelve months from the date of these financial statements.”View the 10-Q filed Aug 17, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Every disclosed holder of RGBP in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns RGBP
13F quarter Sep 30, 2024| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 16 | 0.00% |
| Insiders (Forms 3, 4, 5) | 0 | 0.00% |
| 13D/G-only blocks | 9 | 0.00% |
| Remaining | 1,675,277,478 | 100.00% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 1,675,277,503, the issuer's latest cover-page count restated onto today's split basis.
Insiders are listed but not summed: the issuer has more than one class of common stock and Forms 3, 4 and 5 report one issuer-wide balance across them.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of RGBP
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
THOMPSON INVESTMENT MANAGEMENT, INC.
13F
CIK 1277279 · Registered investment adviser · Sep 30, 2024
Classes RGBP, RGBPP
|
16 | ||
| 2 |
|
9 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.